<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hartz SM</submitter><funding>Intramural NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NIDA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>77-84</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3107398</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(2)</volume><pubmed_abstract>OBJECTIVE:Owing to the clinical relationship between bipolar disorder and nicotine dependence, we investigated two research questions: (i) are genetic associations with nicotine dependence different in individuals with bipolar disorder as compared with individuals without bipolar disorder, and (ii) do loci earlier associated with nicotine dependence have pleiotropic effects on these two diseases. METHOD:Our study consisted of 916 cases with bipolar disorder and 1028 controls. On the basis of known associations with nicotine dependence, we genotyped eight single-nucleotide polymorphisms (SNPs) on chromosome 8 (three bins) in the regions of CHRNB3 and CHRNA6, and six SNPs on chromosome 15 (three bins) in the regions of CHRNA5 and CHRNA3. RESULTS:To determine whether the genetic associations with nicotine dependence are different in bipolar disorder than in the general population, we compared allele frequencies of candidate SNPs between individuals with nicotine dependence only and individuals with both nicotine dependence and bipolar disorder. There were no statistical differences between these frequencies, indicating that genetic association with nicotine dependence is similar in individuals with bipolar disorder as in the general population. In the investigation of pleiotropic effects of these SNPs on bipolar disorder, two highly correlated synonymous SNPs in CHRNB3, rs4952 and rs4953, were significantly associated with bipolar disorder (odds ratio 1.7, 95% confidence interval: 1.2-2.4, P=0.001). This association remained significant both after adjusting for a smoking covariate and analyzing the association in nonsmokers only. CONCLUSION:Our results suggest that (i) bipolar disorder does not modify the association between nicotine dependence and nicotinic receptor subunit genes, and (ii) variants in CHRNB3/CHRNA6 are independently associated with bipolar disorder.</pubmed_abstract><journal>Psychiatric genetics</journal><pubmed_title>Genetic association of bipolar disorder with the ?(3) nicotinic receptor subunit gene.</pubmed_title><pmcid>PMC3107398</pmcid><funding_grant_id>R01 MH59553</funding_grant_id><funding_grant_id>R01 MH60068</funding_grant_id><funding_grant_id>R01 MH059548</funding_grant_id><funding_grant_id>R01 MH059545</funding_grant_id><funding_grant_id>R01 MH059556</funding_grant_id><funding_grant_id>R01 MH059534</funding_grant_id><funding_grant_id>R01 MH059567</funding_grant_id><funding_grant_id>R01 MH059535</funding_grant_id><funding_grant_id>R01 MH059533</funding_grant_id><funding_grant_id>R01 MH094483</funding_grant_id><funding_grant_id>R01 MH060068</funding_grant_id><funding_grant_id>R01 MH059553</funding_grant_id><funding_grant_id>R01 MH59535</funding_grant_id><funding_grant_id>R01 MH59545</funding_grant_id><funding_grant_id>R01 MH59533</funding_grant_id><funding_grant_id>K02 DA021237</funding_grant_id><funding_grant_id>P50CA89392</funding_grant_id><funding_grant_id>R01MH59567</funding_grant_id><funding_grant_id>5K02DA021237</funding_grant_id><funding_grant_id>Z01 MH002810</funding_grant_id><funding_grant_id>K02 DA21237</funding_grant_id><funding_grant_id>P01 CA089392</funding_grant_id><funding_grant_id>KL2 TR000450</funding_grant_id><funding_grant_id>1Z01MH002810-01</funding_grant_id><pubmed_authors>Rice J</pubmed_authors><pubmed_authors>Lin P</pubmed_authors><pubmed_authors>Caserta M</pubmed_authors><pubmed_authors>Bowman ES</pubmed_authors><pubmed_authors>Glitz DA</pubmed_authors><pubmed_authors>Detera-Wadleigh S</pubmed_authors><pubmed_authors>Bierut L</pubmed_authors><pubmed_authors>Miller MJ</pubmed_authors><pubmed_authors>Nwulia E</pubmed_authors><pubmed_authors>Zandi PP</pubmed_authors><pubmed_authors>Nurnberger J</pubmed_authors><pubmed_authors>Hipolito M</pubmed_authors><pubmed_authors>Kelsoe J</pubmed_authors><pubmed_authors>Smiley C</pubmed_authors><pubmed_authors>Kravitz HM</pubmed_authors><pubmed_authors>Murphy DL</pubmed_authors><pubmed_authors>Rochberg N</pubmed_authors><pubmed_authors>Nelson E</pubmed_authors><pubmed_authors>Foroud T</pubmed_authors><pubmed_authors>Vaughn-Brown A</pubmed_authors><pubmed_authors>Meyer ET</pubmed_authors><pubmed_authors>Lawson WB</pubmed_authors><pubmed_authors>Berrettini W</pubmed_authors><pubmed_authors>Xuei X</pubmed_authors><pubmed_authors>Sanders A</pubmed_authors><pubmed_authors>Dinwiddie S</pubmed_authors><pubmed_authors>McKinney R</pubmed_authors><pubmed_authors>Rice JP</pubmed_authors><pubmed_authors>Samavedy N</pubmed_authors><pubmed_authors>MacKinnon DF</pubmed_authors><pubmed_authors>Saccone S</pubmed_authors><pubmed_authors>Reich T</pubmed_authors><pubmed_authors>Edenberg H</pubmed_authors><pubmed_authors>Mondimore FM</pubmed_authors><pubmed_authors>Dick DM</pubmed_authors><pubmed_authors>Edenberg HJ</pubmed_authors><pubmed_authors>Bierut LJ</pubmed_authors><pubmed_authors>DePaulo JR</pubmed_authors><pubmed_authors>Avramopoulos D</pubmed_authors><pubmed_authors>Marta D</pubmed_authors><pubmed_authors>Gershon E</pubmed_authors><pubmed_authors>El-Mallakh R</pubmed_authors><pubmed_authors>Bederow L</pubmed_authors><pubmed_authors>Crowe R</pubmed_authors><pubmed_authors>Harakal D</pubmed_authors><pubmed_authors>McMahon F</pubmed_authors><pubmed_authors>Kassem L</pubmed_authors><pubmed_authors>Rau NL</pubmed_authors><pubmed_authors>Byerley W</pubmed_authors><pubmed_authors>Manji H</pubmed_authors><pubmed_authors>Flury L</pubmed_authors><pubmed_authors>Coryell W</pubmed_authors><pubmed_authors>Nguyen T</pubmed_authors><pubmed_authors>Vinogradov S</pubmed_authors><pubmed_authors>Badner J</pubmed_authors><pubmed_authors>Scheftner W</pubmed_authors><pubmed_authors>McMahon FJ</pubmed_authors><pubmed_authors>Hartz SM</pubmed_authors><pubmed_authors>McInnis M</pubmed_authors><pubmed_authors>Moe PR</pubmed_authors><pubmed_authors>Austin L</pubmed_authors><pubmed_authors>Potash JB</pubmed_authors><pubmed_authors>NIMH Genetics Initiative Bipolar Disorder Consortium</pubmed_authors><pubmed_authors>Goate A</pubmed_authors><pubmed_authors>Liu C</pubmed_authors><pubmed_authors>Payne J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic association of bipolar disorder with the ?(3) nicotinic receptor subunit gene.</name><description>OBJECTIVE:Owing to the clinical relationship between bipolar disorder and nicotine dependence, we investigated two research questions: (i) are genetic associations with nicotine dependence different in individuals with bipolar disorder as compared with individuals without bipolar disorder, and (ii) do loci earlier associated with nicotine dependence have pleiotropic effects on these two diseases. METHOD:Our study consisted of 916 cases with bipolar disorder and 1028 controls. On the basis of known associations with nicotine dependence, we genotyped eight single-nucleotide polymorphisms (SNPs) on chromosome 8 (three bins) in the regions of CHRNB3 and CHRNA6, and six SNPs on chromosome 15 (three bins) in the regions of CHRNA5 and CHRNA3. RESULTS:To determine whether the genetic associations with nicotine dependence are different in bipolar disorder than in the general population, we compared allele frequencies of candidate SNPs between individuals with nicotine dependence only and individuals with both nicotine dependence and bipolar disorder. There were no statistical differences between these frequencies, indicating that genetic association with nicotine dependence is similar in individuals with bipolar disorder as in the general population. In the investigation of pleiotropic effects of these SNPs on bipolar disorder, two highly correlated synonymous SNPs in CHRNB3, rs4952 and rs4953, were significantly associated with bipolar disorder (odds ratio 1.7, 95% confidence interval: 1.2-2.4, P=0.001). This association remained significant both after adjusting for a smoking covariate and analyzing the association in nonsmokers only. CONCLUSION:Our results suggest that (i) bipolar disorder does not modify the association between nicotine dependence and nicotinic receptor subunit genes, and (ii) variants in CHRNB3/CHRNA6 are independently associated with bipolar disorder.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Apr</publication><modification>2020-11-19T10:20:13Z</modification><creation>2019-03-27T00:42:14Z</creation></dates><accession>S-EPMC3107398</accession><cross_references><pubmed>21191315</pubmed><doi>10.1097/ypg.0b013e32834135eb</doi><doi>10.1097/YPG.0b013e32834135eb</doi></cross_references></HashMap>